
Ph.D. candidate at the Centre for Systems Biology, Samuel Lunenfeld Research Institute, University of Toronto
Toronto, Canada Area

Ph.D. candidate at the Centre for Systems Biology, Samuel Lunenfeld Research Institute, University of Toronto
Toronto, Canada Area
• soon-to-be PhD-holder with strong expertise in research, analysis, policy, and project management.
• strong written communication skills from experience preparing a variety of documents: policy statements, position papers, briefing notes, press releases, formal letters, meeting minutes, grant proposals, and scientific manuscripts.
• strong oral communication skills from experience serving on a variety of boards and committees, and from presenting PowerPoint decks on a variety of topics (scientific research, public policy) to a variety of audiences (scientific researchers, government decision-makers, university officials, and the general public).
(Biotechnology industry)
October 2008 — Present (1 year 3 months)
• invited to write commentaries on science policy for MaRS – a non-profit organization focused on maximizing the economic and social impact of Canadian science and technology innovation, by fostering collaboration between academic science, business and capital
• Canada’s science policy takes centre stage in Toronto
http://blog.marsdd.com/2009/11/12/canada-science-policy-takes-centre-stage-in-toronto/
• Budget S&T draws mixed reviews
http://blog.marsdd.com/2009/02/03/budget-st-draws-mixed-reviews/
• Are we producing too many scientists?
http://blog.marsdd.com/2008/11/04/are-we-producing-too-many-scientists/
• The politicization of science in Canada
http://blog.marsdd.com/2008/10/16/the-politicization-of-science-in-canada/
(Non-Profit; Public Policy industry)
September 2008 — Present (1 year 4 months)
• as part of an 18-member team of organizers, developed the aims and scope of Canada’s first in-depth, national-level, multi-sector, multi-disciplinary conference devoted to science policy (http://sciencepolicy.ca)
• drafted the conference’s 30-page Strategic Plan, including an environmental scan to identify a network of ~130 Canadian science policy stakeholders from the government, academic, industry, and non-profit sectors
• drafted a grant proposal to the Canadian Institutes of Health Research (CIHR) that was subsequently funded with the maximum award of $25,000
• prepared and presented PowerPoint decks to: the Parliamentary Assistant to the Ontario Minister of Training, Colleges and Universities; the Vice-President, Research, of the University of Toronto; and 2 general meetings of conference volunteers
• prepared formal correspondence for the Chair's signature (to CEOs, Presidents, Directors, etc)
• drafted press releases and conference announcements
• offered updates and input at 31 Organizing Committee meetings
(Public Policy industry)
September 2008 — Present (1 year 4 months)
• with one co-founder, started a website tracking science policy in Canada’s political arena and media (http://sciencecanada.blogspot.com)
• posted links to ~4,500 press articles and editorials dealing with Canadian public policy in the realms of scientific research and innovation, health, energy, and the environment
(Non-Profit; Publishing industry)
June 2008 — Present (1 year 7 months)
• as part of an 8-member team of Senior Editors, handled the operations of Hypothesis – a peer-reviewed, open-access scientific journal run entirely by a volunteer editorial staff (http://www.hypothesisjournal.com)
• wrote the journal’s editorial policies on: authorship, conflicts of interest, peer review, editorial decisions, redundant publication, media relations, confidentiality, response to allegations of scientific misconduct, corrections & retractions, correspondence, editorial independence, access to data & materials, advertising, and human & animal research
• wrote the journal’s Copyright & License Agreement
• wrote the journal’s Instructions for Authors
• copy-edited 9 manuscripts
• coordinated the peer review of 2 manuscripts
• provided ad-hoc advice to the Senior Editorial Board on policy options and best practices
• offered updates and input at 7 Editorial Board meetings
(Non-Profit; Public Policy industry)
May 2008 — Present (1 year 8 months)
• as part of a 7-member senior executive, guided the research and publishing activities of the CSA – a non-profit, public policy think-tank promoting church-state separation and the neutrality of government in matters of religion (http://www.secularalliance.ca)
• conducted inter-jurisdictional research; developed policy options & recommendations; provided ad-hoc advice to the President
• wrote 6 briefing notes and 6 policy position papers on a variety of topics, including: constitutional law, human rights law, charity law, education policy, and philosophy of science
• directed the activities of a 14-member ad-hoc committee of volunteer researchers
• archived and posted links to ~3,100 press articles and editorials dealing with Canadian public policy in the realm of religious freedom
• reviewed ~700 pages of secondary-school science education materials to evaluate their scientific rigour and consistency with Ontario Ministry of Education policy
• recorded and prepared minutes for 25 Board of Directors meetings
• prepared and presented a PowerPoint deck at the 2009 Centre for Inquiry Canada Annual General Meeting
• acted as administrator and moderator of a Canada-wide e-mail listserv
• handled ~200 information / membership inquiries from the public
(Public Policy industry)
May 2008 — Present (1 year 8 months)
• offered proposal-writing expertise to the FAC – a registered charitable organization promoting public education about critical thinking and scepticism (http://freethoughtassociation.ca)
• wrote 2 grant proposals for submission to external funding agencies
• offered updates and input at 17 Board of Directors meetings
(Non-Profit; Think Tanks industry)
May 2008 — Present (1 year 8 months)
• assisted in the operation of the CFIO – a registered charitable organization promoting evidence-based inquiry into science, pseudoscience, medicine, and ethics (http://www.centerforinquiry.net/ontario)
• helped set up and run 13 public lectures on topics at the interface of science and society; performed various duties, including: introducing speakers; moderating Q&A periods with the audience; handling sale of tickets, books, and magazines; representing the organization in interactions with the public
• offered updates and input at 4 Executive Committee meetings
(Biotechnology industry)
September 2002 — Present (7 years 4 months)
Mike Tyers' lab, Centre for Systems Biology, Samuel Lunenfeld Research Institute, Mount Sinai Hospital; and Department of Molecular Genetics, University of Toronto, Canada (http://www.mshri.on.ca/tyers)
• systematically mapped nutrient-sensing and growth-control pathways in the model organism S. cerevisiae by integrating genome-wide data on phenotypes, subcellular localization, transcript abundance, protein-protein interactions, DNA-protein interactions, and genetic interactions
• constructed a system for small-molecule control of protein function based on fusion to ligand-binding domains
• contributed to the following publications:
i) Bøe CA*, Garcia I*, Pai CC*, Sharom JR*, Skjølberg HC*, Boye E, Kearsey S, Macneill SA, Tyers MD, Grallert B (2008). Rapid regulation of protein activity in fission yeast. BMC Cell Biol. 9, 23.
* contributed equally and share first authorship
ii) Jorgensen P, Rupes I, Sharom JR, Schneper L, Broach JR, Tyers M (2004). A dynamic transcriptional network communicates growth potential to ribosome synthesis and critical cell size. Genes Dev. 18, 2491.
iii) Sharom JR, Bellows DS, Tyers M (2004). From large networks to small molecules. Curr Opin Chem Biol. 8, 81.
(Pharmaceuticals industry)
January 2002 — May 2002 (5 months)
Apoptosis Group, Department of Biochemistry and Molecular Biology, Merck Frosst Centre for Therapeutic Research, Kirkland, QC
• characterized the in-vitro protease activity of a newly-cloned caspase-12 homologue from rat against fluorogenic tetrapeptide and radiolabeled protein substrates
• produced a variety of recombinant human caspases for small-molecule screening assays and polyclonal antibody generation, via their high-level expression and purification from E. coli
• wrote a technical report summarizing the work completed:
Sharom, JR. Cloning, expression and catalytic properties of rat caspase-12. Work-term report for Merck Frosst Canada Ltd. Aug 2001.
• contributed to a peer-reviewed publication:
Roy S*, Sharom JR*, Houde C, Loisel TP, Vaillancourt JP, Shao W, Saleh M, Nicholson DW (2008). Confinement of caspase-12 proteolytic activity to autoprocessing. Proc Natl Acad Sci U S A. 105, 4133.
* contributed equally and share first authorship
(Pharmaceuticals industry)
May 2001 — August 2001 (4 months)
Apoptosis Group, Department of Biochemistry and Molecular Biology, Merck Frosst Centre for Therapeutic Research, Kirkland, QC
• see above entry for January 2002-May 2002
(Government Agency; Government Administration industry)
September 2000 — December 2000 (4 months)
Human Parvovirus B19 Group, Division of Blood-borne Pathogens, Health Canada, Canadian Science Centre for Human and Animal Health, Winnipeg, MB
• assisted in a yeast two-hybrid screen of a human cDNA library to identify novel protein interaction partners for the viral non-structural protein (NS1)
• studied the ability of transfected NS1 to induce apoptosis in human erythroid cell lines by assaying for DNA fragmentation and caspase activation
• wrote a technical report summarizing the work completed:
Sharom, JR. Functional studies of the human parvovirus B19 nonstructural protein (NS1). Work-term report for Health Canada National Microbiology Laboratory. Dec 2000.
(Pharmaceuticals industry)
January 2000 — April 2000 (4 months)
Human Immunodeficiency Virus (HIV) Group, Department of Biological Sciences, Boehringer Ingelheim (Canada) Ltd., Bio-Méga Research Division, Laval, QC
• assisted in the bacterial expression and purification of HIV-1 reverse transcriptase (RT) for high-resolution X-ray crystallographic study, using FPLC and ion-exchange, gel filtration, and affinity chromatography
• performed high-throughput in-vitro enzymatic assays to identify small-molecule inhibitors of HIV-1 RT using the Biomek automated robotic workstation and scintillation proximity assay (SPA) technology
• wrote a technical report summarizing the work completed:
Sharom, JR. Bacterial expression and purification of recombinant human immunodeficiency virus type 1 reverse transcriptase (HIV-1 RT) for high resolution X-ray crystallography. Work-term report for Boehringer Ingelheim Canada Ltd. Apr 2000.
(Pharmaceuticals industry)
January 1999 — April 1999 (4 months)
Human Papillomavirus (HPV) Group, Department of Biological Sciences, Boehringer Ingelheim (Canada) Ltd., Bio-Méga Research Division, Laval, QC
• assisted in the optimization of an in-vitro assay to identify small-molecule inhibitors of the E1 helicase of human papillomavirus
• performed a variety of microplate-format ELISAs and protein-DNA binding assays to screen for inhibitors of other HPV enzymes
• wrote a technical report summarizing the work completed:
Sharom, JR. Optimization of an assay to screen for inhibition of the E1 helicase of human papillomavirus type 11 (HPV-11). Work-term report for Boehringer Ingelheim Canada Ltd. Apr 1999.
• contributed to a peer-reviewed publication:
Jeffery JA, Sharom JR, Fazekas M, Rudd P, Welchner E, Thauvette L, White PW (2002). An ATPase assay using scintillation proximity beads for high-throughput screening or kinetic analysis. Anal Biochem. 304, 55.
Self-directed Learner , Public Policy , 2009 — 2010 (expected)
• 2009 Canadian Science Policy Conference (2.5-day conference on science & innovation policy)
• HealthAchieve 2009 (2.5-day conference on health policy hosted by the Ontario Hospital Association)
• Celebrating Innovations in Health Care Expo 2009 (1-day expo on health policy hosted by the Ontario Ministry of Health and Long-Term Care)
• Public Policy 101 workshop series [2008-2009] (7.5-hour workshop series offered by the George Cedric Metcalf Charitable Foundation)
- What is public policy and why should we be bothered?
- Who's who in government
- How do we develop more effective public policy options?
Self-directed Learner , Intellectual Property and Regulatory Affairs , 2008 — 2010 (expected)
• Research Commercialization Course [2008] (17.5 hours of webinars offered by the National Council of Entrepreneurial Tech Transfer)
• 12 hours of seminars and hands-on workshops offered by Ogilvy Renault LLP [2008]
- How to Draft a Patent Application
- Life Science IP
- IP Strategies for Diagnostics
- IP Strategies for Therapeutics
- IP Strategies for Medical Devices
• Inventions Policy Workshop [2008] (2-hour seminar offered by University of Toronto Intellectual Property & Contracts)
• 3 hours of seminars offered by the Mount Sinai Hospital Office of Technology Transfer & Industrial Liaison
- Introduction to Technology Transfer
- Commercializing the Next Generation of Molecular Diagnostics and Therapeutics
• Good Laboratory Practices (GLP) Course [2008] (7-hour course offered by PharmEng Inc.)
• Navigating the Global Regulatory Path for New Drugs [2008] (2-hour seminar offered by CanReg Inc.)
Ph.D. , Molecular Genetics , 2002 — 2010 (expected)
• cumulative average: A+
• Terry Fox Foundation Research Studentship [2006-2008]
- one of 13 studentships of $47,000 awarded Canada-wide by the National Cancer Institute of Canada (NCIC) biomedical panel.
• NSERC Canada Graduate Scholarship (CGS-D) [2004-2006]
- one of 148 scholarships of $70,000 awarded Canada-wide by the Natural Sciences and Engineering Research Council (NSERC) for pursuit of doctoral studies.
• NSERC Post-Graduate Scholarship A (PGS-A) [2002-2004]
- one of 626 scholarships of $34,600 awarded Canada-wide by the Natural Sciences and Engineering Research Council (NSERC) for pursuit of masters studies.
B.Sc. , Specialized Honours Co-op Biochemistry , 1997 — 2001
• cumulative average: 94.7%
• Governor General’s Academic Silver Medal [2002]
- awarded to the graduating student with the highest university-wide cumulative average of any student in any discipline.
OTHER SELECTED TRAINING
• 4 hours of online courses offered by CharityVillageCampus.com [2008] (accredited by Certified Fund Raising Executive (CFRE) International)
- Proposal Writing
- Grantseeking
• 24 hours of courses offered by the University of Toronto Office of English Language and Writing Support [2003, 2008]
- Thesis Writing in the Life Sciences
- Writing Natural Sciences and Engineering Research Council (NSERC) Proposals
• Teaching Fundamentals Certificate [2008] (12-hour course offered by the University of Toronto Teaching Assistants’ Training Program)
• Leadership Skills for Graduate Students Workshop Series [2007] (12-hour interactive workshop series offered by University of Toronto Student Affairs)
- How to communicate effectively and resolve conflict in a group
- How to facilitate and co-ordinate a group
- Connecting leadership theory to practice